Practice Areas -

Equity Capital Markets Law Firms and Lawyers

  • Search Result as
  • By Days
  • Between Dates

Practice Areas - Equity Capital Markets Law Firms and Lawyers

Deal Date: 06-07-2020 Practice Area: Equity Capital Markets
Deal Title: SK Biopharmaceuticals KRX KOSPI Initial Public Offering Industry: Pharmaceuticals & Biotechnology
Simpson Thacher represented SK Biopharmaceuticals Co., Ltd., as issuer, and SK Holdings Co., Ltd., as selling shareholder, in connection with SK Biopharmaceuticals' initial public offering and listing on the KRX KOSPI Market, which included an international offering pursuant to Rule 144A and Regulation S. The offering raised an aggregate of Won 959.3 billion (approximately USD800.1 million) for SK Biopharmaceuticals and SK Holdings, marking the largest initial public offering in Korea since 2017. Citigroup Global Markets Korea Securities Limited, NH Investment and Securities Co., Ltd., Morgan Stanley and Co. International PLC, Seoul Branch., Korea Investment and Securities Co., Ltd., SK Securities Co., Ltd., and Hana Financial Investment Co., Ltd. acted as underwriters for the offering.
Financial Center: Seoul Value: 500.01-1000.00
Advised Party: Issuer Law Firm
Issuer Jurisdiction- Republic of Korea Listing Jurisdiction- Republic of Korea
Classification: Initial Public Offerings Korea Exchange: KRX KOSPI
Lawyer Jin Hyuk Park